Showing results (721-730 of 1,237) with videos related to
Sort By:
Pageof 124
Cytometry. Part B, Clinical Cytometry|April 28, 2012
Values for αβ and γδ T-lymphocytes and CD4+, CD8+, and CD56+ subsets in healthy adult subjects: assessment by age and genderJ C Andreu-Ballester, C García-Ballesteros, C Benet-Campos, et al.Cytometry. Part B, Clinical Cytometry|May 9, 2012
Automated analysis of GPI-deficient leukocyte flow cytometric data using GemStone™David T Miller, Benjamin C Hunsberger, C Bruce BagwellCytometry. Part B, Clinical Cytometry|February 14, 2012
Ten antibodies, six colors, twelve parameters: a multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin's lymphomasAlessandra Stacchini, Sabrina Aliberti, Anna Demurtas, et al.Cytometry. Part B, Clinical Cytometry|September 15, 2011
ISHAGE protocol: are we doing it correctly?Alison Whitby, Liam Whitby, Matthew Fletcher, et al.Cytometry. Part B, Clinical Cytometry|September 22, 2011
Cryopreservation modulates the detection of regulatory T cell markersSebastian Sattui, Carolina de la Flor, Cesar Sanchez, et al.Cytometry. Part B, Clinical Cytometry|October 28, 2011
Combined normal donor and CLL: Single tube ZAP-70 analysisHeba A Degheidy, David J Venzon, Mohammed Z H Farooqui, et al.Cytometry. Part B, Clinical Cytometry|October 7, 2011
Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS studyFrançoise Durrieu, Franck Geneviève, Christine Arnoulet, et al.Cytometry. Part B, Clinical Cytometry|August 4, 2011
Differential modulation of cord blood and peripheral blood monocytes by intravenous immunoglobulinChristian Gille, Stephan Dreschers, Bärbel Spring, et al.Cytometry. Part B, Clinical Cytometry|November 15, 2011
CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphomaNaveen Dakappagari, Steffan N Ho, Randy D Gascoyne, et al.Cytometry. Part B, Clinical Cytometry|September 22, 2018
Flow cytometric assays for identity, safety and potency of cellular therapiesJohn D M Campbell, Alasdair R FraserPageof 124